Ardent Health Partners, INC Form 4 insider transactions
NYSE
David Schultz, President of Hospital Operations at Ardent Health Partners, reports the acquisition and disposal of company stock.
NYSE
Stephen C. Petrovich, EVP, GC and Asst. Secretary of Ardent Health Partners, reports acquisition and disposal of common stock and restricted stock units.
NYSE
Alfred Lumsdaine, CFO of Ardent Health Partners, reports the acquisition and disposal of company stock, including shares withheld for tax payments and the vesting of restricted stock units.
NYSE
Ardent Health Partners' CEO, Martin Bonick, reports the withholding of shares for tax obligations and the acquisition of restricted stock units.
NYSE
Director Suzanne Campion reports acquisition and disposal of Ardent Health Partners common stock and restricted stock units.
NYSE
Form 4: Ardent Health Partners Director Peter Bynoe Reports Acquisition and Disposal of Common Stock
Director Peter Bynoe reported acquiring and disposing of Ardent Health Partners common stock on March 21, 2025, according to a Form 4 filing.
NYSE
William M. Goodyear, a director of Ardent Health Partners, acquired 12,916 restricted stock units on March 21, 2025, which vest on the first anniversary of the grant date.
NYSE
Director Ellen Havdala acquired 12,916 shares of Ardent Health Partners, Inc. through restricted stock units on March 21, 2025.
NYSE
Director Sen Rahul reports acquisition of 12,916 restricted stock units in Ardent Health Partners, Inc.
NYSE
Mark R. Sotir, a director at Ardent Health Partners, reported the acquisition of shares and changes in beneficial ownership in a recent SEC filing.
NYSE
Director Edmondo Robinson reports acquisition of 12,916 shares and disposal of shares of Ardent Health Partners, Inc. on March 21, 2025.
NYSE
Director Robert Thomas Webb acquired 12,916 shares of Ardent Health Partners, Inc. through restricted stock units on March 21, 2025.
NYSE
Robert Thomas Webb, a director at Ardent Health Partners, acquired 10,793 restricted stock units on December 12, 2024.
NYSE
Director Edmondo Robinson acquired 10,793 restricted stock units in Ardent Health Partners, Inc.
NYSE
Director Ellen Havdala acquired 10,793 shares of Ardent Health Partners common stock through the vesting of restricted stock units.
NYSE
Form 4: Ardent Health Partners Director Peter C B Bynoe Acquires Shares Through Restricted Stock Units
Director Peter C B Bynoe of Ardent Health Partners acquired 10,793 shares of common stock through restricted stock units on December 12, 2024.
NYSE
Director Suzanne Campion acquired 10,793 shares of Ardent Health Partners common stock through the vesting of restricted stock units.
NYSE
Director William M. Goodyear acquired 10,793 shares of Ardent Health Partners common stock on December 12, 2024, through the vesting of restricted stock units.
NYSE
Director Robert Thomas Webb acquired 20,000 shares of Ardent Health Partners stock on November 8, 2024, increasing his holdings.
NYSE
Form 4: Ardent Health Partners EVP Stephen C. Petrovich Reports Acquisition of Restricted Stock Units
Stephen C. Petrovich, EVP, GC and Asst. Secretary of Ardent Health Partners, reports the acquisition of 9,699 restricted stock units and adjustments to his beneficial ownership.
NYSE
Alfred Lumsdaine, CFO of Ardent Health Partners, reports the acquisition of restricted stock units and subsequent beneficial ownership of common stock.
NYSE
David Schultz, President of Hospital Operations at Ardent Health Partners, acquired 16,535 shares of common stock on September 25, 2024.
NYSE
David Raynor Byers, SVP & Chief Accounting Officer of Ardent Health Partners, acquired 6,447 restricted stock units on September 25, 2024.
NYSE
Form 4: Ardent Health Partners Executive VP Stephen Petrovich Reports Changes in Beneficial Ownership
Executive VP, GC, and Secretary of Ardent Health Partners, Stephen C. Petrovich, reports acquisition and disposal of common stock and adjustments to holdings in family trusts.
NYSE
Robert Thomas Webb, a director of Ardent Health Partners, reports acquiring and disposing of common stock on July 18, 2024.
NYSE
Form 4: Ardent Health Partners Director Mark R. Sotir Reports Acquisition of 11,562 Common Stock Units
Mark R. Sotir, a director at Ardent Health Partners, reported acquiring 11,562 common stock units on July 18, 2024.
NYSE
Director Sen Rahul acquired 11,562 shares of Ardent Health Partners common stock on July 18, 2024.
NYSE
Director Edmondo Robinson acquired 11,562 shares of Ardent Health Partners through restricted stock units on July 18, 2024.
NYSE
Director Ellen Havdala reported acquiring 11,562 shares of Ardent Health Partners common stock on July 18, 2024.
NYSE
Director William M. Goodyear reports acquisition of 11,562 shares of Ardent Health Partners, Inc. common stock.